nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—NR3C2—Betamethasone—psoriatic arthritis	0.306	0.342	CbGbCtD
Nimodipine—NR3C2—Prednisolone—psoriatic arthritis	0.302	0.338	CbGbCtD
Nimodipine—NR3C2—Dexamethasone—psoriatic arthritis	0.178	0.199	CbGbCtD
Nimodipine—CACNA1S—pes—psoriatic arthritis	0.0333	0.696	CbGeAlD
Nimodipine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0217	0.0242	CbGbCtD
Nimodipine—CYP3A5—Dexamethasone—psoriatic arthritis	0.021	0.0235	CbGbCtD
Nimodipine—CYP3A4—Triamcinolone—psoriatic arthritis	0.0164	0.0184	CbGbCtD
Nimodipine—CYP3A4—Betamethasone—psoriatic arthritis	0.0141	0.0158	CbGbCtD
Nimodipine—CYP3A4—Prednisolone—psoriatic arthritis	0.0139	0.0155	CbGbCtD
Nimodipine—CYP3A4—Prednisone—psoriatic arthritis	0.0131	0.0147	CbGbCtD
Nimodipine—CYP3A4—Dexamethasone—psoriatic arthritis	0.00819	0.00916	CbGbCtD
Nimodipine—CACNB4—tendon—psoriatic arthritis	0.00298	0.0623	CbGeAlD
Nimodipine—CACNA1S—tendon—psoriatic arthritis	0.00255	0.0533	CbGeAlD
Nimodipine—CACNB1—tendon—psoriatic arthritis	0.00238	0.0497	CbGeAlD
Nimodipine—CACNB3—tendon—psoriatic arthritis	0.00228	0.0477	CbGeAlD
Nimodipine—Gastrointestinal haemorrhage—Auranofin—psoriatic arthritis	0.00193	0.0333	CcSEcCtD
Nimodipine—AHR—tendon—psoriatic arthritis	0.00169	0.0353	CbGeAlD
Nimodipine—CACNB2—tendon—psoriatic arthritis	0.00153	0.032	CbGeAlD
Nimodipine—Jaundice—Auranofin—psoriatic arthritis	0.00145	0.025	CcSEcCtD
Nimodipine—NR3C2—tendon—psoriatic arthritis	0.00113	0.0235	CbGeAlD
Nimodipine—Anaemia—Auranofin—psoriatic arthritis	0.00107	0.0185	CcSEcCtD
Nimodipine—Acne—Prednisolone—psoriatic arthritis	0.00101	0.0174	CcSEcCtD
Nimodipine—Thrombocytopenia—Auranofin—psoriatic arthritis	0.000927	0.016	CcSEcCtD
Nimodipine—Acne—Triamcinolone—psoriatic arthritis	0.000924	0.016	CcSEcCtD
Nimodipine—Acne—Methylprednisolone—psoriatic arthritis	0.000922	0.0159	CcSEcCtD
Nimodipine—Deep vein thrombosis—Methotrexate—psoriatic arthritis	0.000844	0.0146	CcSEcCtD
Nimodipine—Acne—Betamethasone—psoriatic arthritis	0.000839	0.0145	CcSEcCtD
Nimodipine—Acne—Dexamethasone—psoriatic arthritis	0.000839	0.0145	CcSEcCtD
Nimodipine—Fluid retention—Prednisolone—psoriatic arthritis	0.000803	0.0139	CcSEcCtD
Nimodipine—Wheezing—Triamcinolone—psoriatic arthritis	0.000755	0.0131	CcSEcCtD
Nimodipine—Fluid retention—Triamcinolone—psoriatic arthritis	0.000739	0.0128	CcSEcCtD
Nimodipine—Fluid retention—Methylprednisolone—psoriatic arthritis	0.000737	0.0127	CcSEcCtD
Nimodipine—Acne—Prednisone—psoriatic arthritis	0.000731	0.0126	CcSEcCtD
Nimodipine—Cardiac failure congestive—Prednisolone—psoriatic arthritis	0.000677	0.0117	CcSEcCtD
Nimodipine—Fluid retention—Betamethasone—psoriatic arthritis	0.00067	0.0116	CcSEcCtD
Nimodipine—Fluid retention—Dexamethasone—psoriatic arthritis	0.00067	0.0116	CcSEcCtD
Nimodipine—Pruritus—Auranofin—psoriatic arthritis	0.00067	0.0116	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Methylprednisolone—psoriatic arthritis	0.000648	0.0112	CcSEcCtD
Nimodipine—Diarrhoea—Auranofin—psoriatic arthritis	0.000648	0.0112	CcSEcCtD
Nimodipine—Cardiac failure congestive—Triamcinolone—psoriatic arthritis	0.000623	0.0108	CcSEcCtD
Nimodipine—Cardiac failure congestive—Methylprednisolone—psoriatic arthritis	0.000621	0.0107	CcSEcCtD
Nimodipine—Vomiting—Auranofin—psoriatic arthritis	0.000602	0.0104	CcSEcCtD
Nimodipine—Rash—Auranofin—psoriatic arthritis	0.000597	0.0103	CcSEcCtD
Nimodipine—Dermatitis—Auranofin—psoriatic arthritis	0.000596	0.0103	CcSEcCtD
Nimodipine—Fluid retention—Prednisone—psoriatic arthritis	0.000584	0.0101	CcSEcCtD
Nimodipine—Cardiac failure congestive—Dexamethasone—psoriatic arthritis	0.000565	0.00976	CcSEcCtD
Nimodipine—Cardiac failure congestive—Betamethasone—psoriatic arthritis	0.000565	0.00976	CcSEcCtD
Nimodipine—Nausea—Auranofin—psoriatic arthritis	0.000562	0.00972	CcSEcCtD
Nimodipine—Sweating increased—Prednisolone—psoriatic arthritis	0.000517	0.00893	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Methylprednisolone—psoriatic arthritis	0.000497	0.00859	CcSEcCtD
Nimodipine—Cardiac failure congestive—Prednisone—psoriatic arthritis	0.000492	0.0085	CcSEcCtD
Nimodipine—Sweating increased—Triamcinolone—psoriatic arthritis	0.000475	0.00822	CcSEcCtD
Nimodipine—Sweating increased—Methylprednisolone—psoriatic arthritis	0.000474	0.0082	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Prednisone—psoriatic arthritis	0.000446	0.00771	CcSEcCtD
Nimodipine—Bradycardia—Prednisolone—psoriatic arthritis	0.000432	0.00747	CcSEcCtD
Nimodipine—Sweating increased—Dexamethasone—psoriatic arthritis	0.000431	0.00745	CcSEcCtD
Nimodipine—Sweating increased—Betamethasone—psoriatic arthritis	0.000431	0.00745	CcSEcCtD
Nimodipine—Bradycardia—Triamcinolone—psoriatic arthritis	0.000398	0.00687	CcSEcCtD
Nimodipine—Bradycardia—Methylprednisolone—psoriatic arthritis	0.000397	0.00686	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.000394	0.0068	CcSEcCtD
Nimodipine—Sweating increased—Prednisone—psoriatic arthritis	0.000376	0.00649	CcSEcCtD
Nimodipine—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.000362	0.00625	CcSEcCtD
Nimodipine—Bradycardia—Dexamethasone—psoriatic arthritis	0.000361	0.00624	CcSEcCtD
Nimodipine—Bradycardia—Betamethasone—psoriatic arthritis	0.000361	0.00624	CcSEcCtD
Nimodipine—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000354	0.00611	CcSEcCtD
Nimodipine—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000352	0.00608	CcSEcCtD
Nimodipine—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.000344	0.00595	CcSEcCtD
Nimodipine—Depression—Prednisone—psoriatic arthritis	0.000343	0.00592	CcSEcCtD
Nimodipine—Angiopathy—Betamethasone—psoriatic arthritis	0.000322	0.00556	CcSEcCtD
Nimodipine—Angiopathy—Dexamethasone—psoriatic arthritis	0.000322	0.00556	CcSEcCtD
Nimodipine—Hypertension—Prednisolone—psoriatic arthritis	0.000319	0.00552	CcSEcCtD
Nimodipine—Bradycardia—Prednisone—psoriatic arthritis	0.000314	0.00543	CcSEcCtD
Nimodipine—Oedema—Prednisolone—psoriatic arthritis	0.000302	0.00522	CcSEcCtD
Nimodipine—Tachycardia—Prednisolone—psoriatic arthritis	0.000295	0.00509	CcSEcCtD
Nimodipine—Hypertension—Triamcinolone—psoriatic arthritis	0.000294	0.00507	CcSEcCtD
Nimodipine—Hypertension—Methylprednisolone—psoriatic arthritis	0.000293	0.00506	CcSEcCtD
Nimodipine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000292	0.00504	CcSEcCtD
Nimodipine—Myalgia—Triamcinolone—psoriatic arthritis	0.00029	0.005	CcSEcCtD
Nimodipine—Myalgia—Methylprednisolone—psoriatic arthritis	0.000289	0.00499	CcSEcCtD
Nimodipine—Depression—Methotrexate—psoriatic arthritis	0.000287	0.00495	CcSEcCtD
Nimodipine—Flushing—Prednisone—psoriatic arthritis	0.000286	0.00495	CcSEcCtD
Nimodipine—Angiopathy—Prednisone—psoriatic arthritis	0.00028	0.00484	CcSEcCtD
Nimodipine—Immune system disorder—Prednisone—psoriatic arthritis	0.000279	0.00482	CcSEcCtD
Nimodipine—Oedema—Triamcinolone—psoriatic arthritis	0.000278	0.0048	CcSEcCtD
Nimodipine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000272	0.0047	CcSEcCtD
Nimodipine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000272	0.00469	CcSEcCtD
Nimodipine—Tachycardia—Triamcinolone—psoriatic arthritis	0.000271	0.00468	CcSEcCtD
Nimodipine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00027	0.00467	CcSEcCtD
Nimodipine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000268	0.00464	CcSEcCtD
Nimodipine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000268	0.00463	CcSEcCtD
Nimodipine—Hypertension—Betamethasone—psoriatic arthritis	0.000266	0.0046	CcSEcCtD
Nimodipine—Hypertension—Dexamethasone—psoriatic arthritis	0.000266	0.0046	CcSEcCtD
Nimodipine—Myalgia—Dexamethasone—psoriatic arthritis	0.000263	0.00454	CcSEcCtD
Nimodipine—Myalgia—Betamethasone—psoriatic arthritis	0.000263	0.00454	CcSEcCtD
Nimodipine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000259	0.00447	CcSEcCtD
Nimodipine—Hepatitis—Methotrexate—psoriatic arthritis	0.000258	0.00446	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000253	0.00437	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000252	0.00436	CcSEcCtD
Nimodipine—Oedema—Betamethasone—psoriatic arthritis	0.000252	0.00435	CcSEcCtD
Nimodipine—Oedema—Dexamethasone—psoriatic arthritis	0.000252	0.00435	CcSEcCtD
Nimodipine—Anaemia—Prednisone—psoriatic arthritis	0.000248	0.00429	CcSEcCtD
Nimodipine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000247	0.00428	CcSEcCtD
Nimodipine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000247	0.00427	CcSEcCtD
Nimodipine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000247	0.00427	CcSEcCtD
Nimodipine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000247	0.00426	CcSEcCtD
Nimodipine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000247	0.00426	CcSEcCtD
Nimodipine—Tachycardia—Betamethasone—psoriatic arthritis	0.000246	0.00425	CcSEcCtD
Nimodipine—Tachycardia—Dexamethasone—psoriatic arthritis	0.000246	0.00425	CcSEcCtD
Nimodipine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000243	0.00421	CcSEcCtD
Nimodipine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000243	0.00421	CcSEcCtD
Nimodipine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000239	0.00414	CcSEcCtD
Nimodipine—Hypotension—Dexamethasone—psoriatic arthritis	0.000235	0.00407	CcSEcCtD
Nimodipine—Hypotension—Betamethasone—psoriatic arthritis	0.000235	0.00407	CcSEcCtD
Nimodipine—Angiopathy—Methotrexate—psoriatic arthritis	0.000234	0.00404	CcSEcCtD
Nimodipine—Immune system disorder—Methotrexate—psoriatic arthritis	0.000233	0.00403	CcSEcCtD
Nimodipine—Hypertension—Prednisone—psoriatic arthritis	0.000232	0.00401	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000229	0.00396	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000229	0.00396	CcSEcCtD
Nimodipine—Myalgia—Prednisone—psoriatic arthritis	0.000229	0.00395	CcSEcCtD
Nimodipine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000222	0.00384	CcSEcCtD
Nimodipine—Oedema—Prednisone—psoriatic arthritis	0.000219	0.00379	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000217	0.00376	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000217	0.00376	CcSEcCtD
Nimodipine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000215	0.00372	CcSEcCtD
Nimodipine—Tachycardia—Prednisone—psoriatic arthritis	0.000214	0.0037	CcSEcCtD
Nimodipine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000212	0.00366	CcSEcCtD
Nimodipine—Anaemia—Methotrexate—psoriatic arthritis	0.000208	0.00359	CcSEcCtD
Nimodipine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000204	0.00353	CcSEcCtD
Nimodipine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000204	0.00353	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.0002	0.00345	CcSEcCtD
Nimodipine—Dizziness—Prednisolone—psoriatic arthritis	0.0002	0.00345	CcSEcCtD
Nimodipine—Pruritus—Triamcinolone—psoriatic arthritis	0.000196	0.00339	CcSEcCtD
Nimodipine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000196	0.00339	CcSEcCtD
Nimodipine—Myalgia—Methotrexate—psoriatic arthritis	0.000191	0.0033	CcSEcCtD
Nimodipine—Rash—Prednisolone—psoriatic arthritis	0.00019	0.00329	CcSEcCtD
Nimodipine—Dermatitis—Prednisolone—psoriatic arthritis	0.00019	0.00329	CcSEcCtD
Nimodipine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000189	0.00327	CcSEcCtD
Nimodipine—Headache—Prednisolone—psoriatic arthritis	0.000189	0.00327	CcSEcCtD
Nimodipine—Dizziness—Triamcinolone—psoriatic arthritis	0.000184	0.00317	CcSEcCtD
Nimodipine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000183	0.00316	CcSEcCtD
Nimodipine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00018	0.00311	CcSEcCtD
Nimodipine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000179	0.0031	CcSEcCtD
Nimodipine—Nausea—Prednisolone—psoriatic arthritis	0.000179	0.0031	CcSEcCtD
Nimodipine—Pruritus—Dexamethasone—psoriatic arthritis	0.000178	0.00308	CcSEcCtD
Nimodipine—Pruritus—Betamethasone—psoriatic arthritis	0.000178	0.00308	CcSEcCtD
Nimodipine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000177	0.00306	CcSEcCtD
Nimodipine—Vomiting—Triamcinolone—psoriatic arthritis	0.000176	0.00305	CcSEcCtD
Nimodipine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000176	0.00304	CcSEcCtD
Nimodipine—Rash—Triamcinolone—psoriatic arthritis	0.000175	0.00302	CcSEcCtD
Nimodipine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000175	0.00302	CcSEcCtD
Nimodipine—Rash—Methylprednisolone—psoriatic arthritis	0.000175	0.00302	CcSEcCtD
Nimodipine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000174	0.00301	CcSEcCtD
Nimodipine—Headache—Triamcinolone—psoriatic arthritis	0.000174	0.003	CcSEcCtD
Nimodipine—Headache—Methylprednisolone—psoriatic arthritis	0.000173	0.003	CcSEcCtD
Nimodipine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000172	0.00298	CcSEcCtD
Nimodipine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000172	0.00298	CcSEcCtD
Nimodipine—Hypotension—Methotrexate—psoriatic arthritis	0.000171	0.00296	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000167	0.00289	CcSEcCtD
Nimodipine—Dizziness—Dexamethasone—psoriatic arthritis	0.000167	0.00288	CcSEcCtD
Nimodipine—Dizziness—Betamethasone—psoriatic arthritis	0.000167	0.00288	CcSEcCtD
Nimodipine—Nausea—Triamcinolone—psoriatic arthritis	0.000165	0.00285	CcSEcCtD
Nimodipine—Nausea—Methylprednisolone—psoriatic arthritis	0.000164	0.00284	CcSEcCtD
Nimodipine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000163	0.00282	CcSEcCtD
Nimodipine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000162	0.00279	CcSEcCtD
Nimodipine—Vomiting—Dexamethasone—psoriatic arthritis	0.00016	0.00277	CcSEcCtD
Nimodipine—Vomiting—Betamethasone—psoriatic arthritis	0.00016	0.00277	CcSEcCtD
Nimodipine—Rash—Betamethasone—psoriatic arthritis	0.000159	0.00274	CcSEcCtD
Nimodipine—Rash—Dexamethasone—psoriatic arthritis	0.000159	0.00274	CcSEcCtD
Nimodipine—Dermatitis—Betamethasone—psoriatic arthritis	0.000159	0.00274	CcSEcCtD
Nimodipine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000159	0.00274	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000158	0.00273	CcSEcCtD
Nimodipine—Headache—Dexamethasone—psoriatic arthritis	0.000158	0.00273	CcSEcCtD
Nimodipine—Headache—Betamethasone—psoriatic arthritis	0.000158	0.00273	CcSEcCtD
Nimodipine—Pruritus—Prednisone—psoriatic arthritis	0.000155	0.00268	CcSEcCtD
Nimodipine—Diarrhoea—Prednisone—psoriatic arthritis	0.00015	0.00259	CcSEcCtD
Nimodipine—Nausea—Dexamethasone—psoriatic arthritis	0.00015	0.00258	CcSEcCtD
Nimodipine—Nausea—Betamethasone—psoriatic arthritis	0.00015	0.00258	CcSEcCtD
Nimodipine—Dizziness—Prednisone—psoriatic arthritis	0.000145	0.00251	CcSEcCtD
Nimodipine—Vomiting—Prednisone—psoriatic arthritis	0.000139	0.00241	CcSEcCtD
Nimodipine—Rash—Prednisone—psoriatic arthritis	0.000138	0.00239	CcSEcCtD
Nimodipine—Dermatitis—Prednisone—psoriatic arthritis	0.000138	0.00239	CcSEcCtD
Nimodipine—Headache—Prednisone—psoriatic arthritis	0.000137	0.00237	CcSEcCtD
Nimodipine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000135	0.00233	CcSEcCtD
Nimodipine—Nausea—Prednisone—psoriatic arthritis	0.00013	0.00225	CcSEcCtD
Nimodipine—Pruritus—Methotrexate—psoriatic arthritis	0.00013	0.00224	CcSEcCtD
Nimodipine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000125	0.00217	CcSEcCtD
Nimodipine—Dizziness—Methotrexate—psoriatic arthritis	0.000121	0.00209	CcSEcCtD
Nimodipine—Vomiting—Methotrexate—psoriatic arthritis	0.000117	0.00201	CcSEcCtD
Nimodipine—Rash—Methotrexate—psoriatic arthritis	0.000116	0.002	CcSEcCtD
Nimodipine—Dermatitis—Methotrexate—psoriatic arthritis	0.000115	0.002	CcSEcCtD
Nimodipine—Headache—Methotrexate—psoriatic arthritis	0.000115	0.00198	CcSEcCtD
Nimodipine—Nausea—Methotrexate—psoriatic arthritis	0.000109	0.00188	CcSEcCtD
